Search results
Author(s):
Michael R Zile
Added:
1 year ago
HFA 24 - We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.RELIEVE-HF is designed to evaluate the safety and effectiveness of the V-Wave interatrial shunt system in patients with heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure, who had…
View more
Author(s):
Harriette Van Spall
,
Gregg Stone
Added:
1 year ago
ACC 2024 — Late-breaker host Dr Harriette Van Spall (McMaster University, CA) welcomes Principal Investigator Dr Gregg Stone (Icahn School of Medicine at Mount Sinai, New York, NY, US) to discuss the REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure (NCT03499236) (V-Wave Ltd).The RELIEVE-HF trial aims to assess the safety and efficacy of a new device, the V-Wave…
View more
ECG in Severe COVID-19 Infection
Author(s):
Kapil Rajendran
,
Baiju Rajan
,
Sivaprasad Kunjukrishnapilla
,
et al
Added:
1 year ago
Article
Author(s):
Stefan Anker
Added:
1 year ago
HFA 24 - Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE) joins us in this succinct interview to outline the findings of the RELIEVE-HF trial (NCT03499236).RELIEVE-HF was designed to evaluate the safety and effectiveness of the V-Wave inter-atrial shunt system to reduce lung congestion in patients with advanced heart failure. 605 participants with New York Heart Association (NYHA)…
View more
Justin E Davies
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Gregg Stone
Added:
9 months ago
THT Conference 2025 - Outcomes after heart failure patients were treated with an interatrial shunt show heart failure with reduced ejection fraction (HFrEF) patients had further benefit compared to heart failure with preserved ejection fraction (HFpEF) patients. The study's prediction model revealed four independent predictors of two-year adverse outcomes in HFrEF patients treated with medical…
View more
John Sapp
Job title: Clinical Cardiac Electrophysiologist
Author
Author(s):
Nicolas M Van Mieghem
Added:
1 month ago
NVM Cardiology Conference Reflections: What’s Hot at AHA 2025?Join Prof Nicolas Van Mieghem, Transcatheter Interventions Online Course Director, as he shares his perspective on the most anticipated late-breaking science from AHA 2025; the year’s defining moments in structural, coronary therapeutics.What transformative data should we expect at this year’s meeting? Which studies will challenge…
View more
NY Valves 2025 Late-Breaking Science Collection
Video Series